Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
- Dan P Zandberg
- , Jacob B Allred
- , Ari J Rosenberg
- , John M Kaczmar
- , Paul Swiecicki
- , Ricklie A Julian
- , Andrew S Poklepovic
- , Jessica R Bauman
- , Minh D Phan
- , Nabil F Saba
- , Edgardo Rivera
- , Kendrith Rowland
- , Diwakar Davar
- , Julia Cordes
- , Alan L Ho
- , Miao Zhang
- , Stephanie A Berg
- , Pamela N Munster
- , Gary K Schwartz
- University of Pittsburgh
- Alliance Statistics and Data Management Center
- University of Chicago
- Hollings Cancer Center
- University of Michigan Rogel Cancer Center
- University of Arizona Cancer Center
- Virginia Commonwealth University Health System
- Temple University Health Systems
- University of Oklahoma Health Sciences Center
- Winship Cancer Institute of Emory University
- Nevada Cancer Specialists
- Carle Cancer Center
- Mayo Clinic
- Memorial Sloan-Kettering Cancer Center
- MD Anderson Cancer Center
- Dana-Farber/Partners CancerCare
- UCSF Helen Diller Family Comprehensive Cancer Center
- Case Western Reserve University
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations